AdaptHealth Corp. Common Stock

AHCO

AdaptHealth Corp. (AHCO) is a leading provider of in-home delivery and compliance solutions for medical equipment and supplies. The company primarily serves patients requiring respiratory care, infusion therapy, wound care, and various other home healthcare services. AdaptHealth focuses on delivering value through patient-centered care and operational efficiency across its nationwide network.

$10.04 -0.46 (-4.38%)
🚫 AdaptHealth Corp. Common Stock does not pay dividends

Company News

AdaptHealth (AHCO) Q2 Revenue Falls 1%
The Motley Fool • Jesterai • August 6, 2025

AdaptHealth reported lower Q2 2025 revenue and profits, with challenges in Diabetes and Sleep Health segments. The company divested certain assets, reduced debt, and maintained cautious guidance for fiscal 2025.

4 'Strong Buy' Stocks Under $10 with Up to 55% Upside
Investing.com • Jesse Cohen • July 18, 2025

The article highlights four undervalued stocks under $10 with significant growth potential across digital advertising, home healthcare, energy infrastructure, and social media sectors, each offering potential upside between 43-55%.

3 Wallet-Friendly Stocks Under $10 With Significant Upside Potential
Investing.com • Jesse Cohen • February 7, 2025

The article highlights three undervalued stocks under $10 - AdaptHealth, ADT, and Olo - that have strong growth potential and attractive fundamentals.

Why AdaptHealth Stock Got Thrashed on Tuesday
The Motley Fool • Eric Volkman • November 5, 2024

AdaptHealth, a home healthcare services company, reported weaker-than-expected Q3 results, missing analyst estimates for revenue and earnings. The company also reduced its full-year guidance for revenue and adjusted EBITDA, citing growth opportunities and investments. However, it lifted its 2024 free cash flow guidance.

Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
Zacks Investment Research • Zacks Equity Research • June 17, 2024

KARL STORZ is set to acquire all of the outstanding shares of Asensus Surgical (ASXC) for $0.35 per share in cash, making Asensus a subsidiary of KARL STORZ.

Related Companies